Brown Brothers Harriman & CO Regeneron Pharmaceuticals, Inc. Transaction History
Brown Brothers Harriman & CO
- $14 Billion
- Q3 2024
A detailed history of Brown Brothers Harriman & CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 482 shares of REGN stock, worth $342,220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
482
Previous 484
0.41%
Holding current value
$342,220
Previous $508,000
0.39%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding REGN
# of Institutions
1,484Shares Held
83.7MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.62 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.32 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.48 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.05 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...